AI Predicts Protein Aggregation from Sequence to Address Neurological Disease
Researchers headed by a team at the Centre for Genomic Regulation, Barcelona Institute of Science and Technology and at the Wellcome Sanger Institute have developed an AI tool that they say has made a...
EpCAM Links Cervical Lymph Node Metastasis
In a groundbreaking new study, researchers have unveiled a compelling link between the overexpression of the epithelial cell adhesion molecule (EpCAM) and cervical lymph node metastasis (CLNM) in papillary thyroid carcinoma (PTC). This discovery...
HonorHealth Research Institute treats first patient in global trial targeting aggressive melanoma
HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of skin cancer. This new...
Merck KGaA to Acquire SpringWorks for $3.9B, Expanding Rare Cancer Footprint
Two months after saying it was in advanced talks to acquire SpringWorks Therapeutics, Merck KGaA, Darmstadt, Germany, has announced it agreed to purchase the developer of drugs for severe rare disease and cancer for...
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 protein...
Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma
A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute (IR Sant Pau), in conjunction with Sant Pau Hospital and the Josep Carreras Leukaemia...
Complete Genomics and Velsera Partner to Integrate Sequencing and Analysis Platforms
Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data analysis solution.
The partnership, announced at the AACR annual meeting...
Integrating Exercise and Rehabilitation into Breast Cancer Care: A New Frontier
A groundbreaking randomized controlled trial has recently illuminated the promising potential of a pioneering program designed to systematically connect breast cancer patients with tailored exercise and rehabilitation services, beginning at the point of diagnosis...
StockWatch: Tools Giants Foresee Revenue Impacts from Tariffs, Job Cuts
Looming tariffs and recent job cuts from Washington have impacted two of the largest biotech tools companies that released first-quarter results this past week, prompting one to lower its earnings guidance to investors for...
Human Evolution’s Response to Rising Obesity
Obesity has long been considered a modern epidemic, driven primarily by environmental factors such as calorie-rich diets and sedentary lifestyles. However, new insights from a recent article published in the International Journal of Obesity...
